Job Information
- Organisation/Company
- Radboud University Medical Center (Radboudumc)
- Research Field
- Medical sciencesPhysics
- Researcher Profile
- Recognised Researcher (R2)
- Country
- Netherlands
- Application Deadline
- Type of Contract
- Temporary
- Job Status
- Not Applicable
- Hours Per Week
- 36.0
- Is the job funded through the EU Research Framework Programme?
- Not funded by an EU programme
- Is the Job related to staff position within a Research Infrastructure?
- No
Offer Description
We are looking for an ambitious postdoctoral researcher to investigate key regulators of CD20, CD22, and CD37 expression in B-cell non-Hodgkin lymphoma, aiming to enhance antibody-based therapies for improved treatment outcomes. Are you ready to think further for our patients and our care?
B-cell non-Hodgkin lymphoma (B-NHL), the most common hematological malignancy worldwide, still remains a clinical problem. Immunotherapy with rituximab, which targets CD20, is a cornerstone drug in the treatment of many B-NHL patients, including diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL). However, decreased expression levels of membrane targets (CD20, CD22, CD37) in B-NHL is related to refractory/relapsed disease and poor prognosis.
The aim of this project is to define key regulators that control expression of CD20, CD22 and CD37 at the surface of malignant B cells, and to identify compounds that increase target molecule availability to increase the impact of antibody-based treatment in B-NHL. We will combine unbiased genetic and compound screens, and a candidate-based approach with antibody-based therapy in human B-NHL cell lines, primary DLBCL and CLL patient samples and lymphoma mouse models.
This research will provide molecular and biological insight into the underlying mechanisms of antibody resistance, and improve antibody-based treatment outcome in B-NHL patients.
Requirements
You are a creative and motivated researcher with a PhD degree in biomedical sciences/ molecular biology (or equivalent). You will set-up CRISPR/Cas9 screens in B-NHL cells to identify key regulators of CD20/CD22/CD37 in collaboration with the Dutch Cancer Institute (NKI).
Novel candidates will be validated in lymphoma cytotoxicity assays, B-NHL patient tissues and in vivo lymphoma models. Experience with molecular biology and cell biological techniques is a must. A permit to work with animals (or willing to obtain this) is an advantage.
Additional Information
At Radboud university medical center, you build on your future. We are committed to providing the best care, education, and research. And we are true to our word, because we help you develop and seize opportunities and give you the room to grow. As an employer, we believe that employees should feel vital and happy at work in all stages of life. We are also committed to creating a healthy and safe working environment. Our employment conditions contribute to that. What we offer:
- A gross monthly salary in scale 10 between € 3.359 and € 5.292 (for a full-time appointment). You will also receive an 8% holiday allowance, an 8.3% end-of-year bonus, and a 47% to 72% bonus for working unsocial hours.
- Plenty of opportunities to develop yourself. For example, you can follow various courses via our online learning environment. A lot of attention will also be paid to your wellbeing and vitality. For instance, you can take advantage of:
- a 40% discount on gym membership at the Radboud Sports Center.
- the Company Support Team and a personal coach if you experience a life-changing event.
- a financially favorable option to work less through a generation scheme if you are approaching state retirement age.
- support with achieving a good work-life balance at every stage of your life. This includes advice and training (from ‘Millennial Dilemmas’ to ‘Your Career After 57’), activities at our own mindfulness center, and informal caregiving consultations if you have any questions about combining your work and caregiving tasks at home.
- 168 vacation hours per year based on a 36-hour working week. Want more vacation? You can buy additional vacation hours with your end-of-year bonus.
- 26 weeks of parental leave, of which 9 weeks are paid.
- Extra-favorable leave conditions. For example, our short-term caregiving leave is not 2 but 4 weeks per year and even 12 weeks per year for partner and child.
- Pension accrual with the ABP Pension Fund. Radboud university medical center pays 70% of the pension contribution.
- Discount on the supplementary packages of two collective health insurance policies and on ten other types of insurance, from home insurance to legal assistance.
- A travel allowance via our Employment Conditions Selection Model and a working-from-home allowance of €2 per day.
Any questions? Or wondering what it is like to work at Radboudumc? Then call, send a message or email to Annemiek van Spriel, Full Professor Experimental Immunology. Use the Apply button to submit your application.
Any questions? Or wondering what it is like to work at Radboudumc? Then call, send a message or email to Annemiek van Spriel, Full Professor Experimental Immunology. Use the Apply button to submit your application.
- Website for additional job details
Work Location(s)
- Number of offers available
- 1
- Company/Institute
- Radboudumc
- Country
- Netherlands
- City
- Nijmegen
- Postal Code
- 6525 GA
- Street
- Geert Grooteplein-Zuid 10
- Geofield
Where to apply
- Website
Contact
- City
- Nijmegen
- Website
- Street
- Geert Grooteplein-Zuid 10
- Postal Code
- 6525 GA